Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can ...

Cross Country Healthcare has seen a material decline in their share price, down 60% from the high in November 2022 following the travel nurse industry declines. There's likely still more softness ...

For the quarter ended September 2024, Cross Country Healthcare (CCRN) reported revenue of $315.12 million, down 28.8% over the same period last year. EPS came in at $0.12, compared to $0.39 in the ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Cross Country Healthcare (CCRN) reports results for the quarter ended June 2025. While this widely-known consensus ...

Cross Country Healthcare's stock performance suggests investors expect a challenging period for the company. Long-term tailwinds include high capital turnover, compounding earnings, compressed ...

CCRN is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of CCRN shares has decreased $0.07 since the market last closed. This is a 0.71 ...

The latest price target for Cross Country Healthcare (NASDAQ:CCRN) was reported by UBS on December 9, 2025. The analyst firm set a price target for $9.00 expecting CCRN to rise to within 12 months (a ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2025 Earnings Call Transcript March 4, 2026 Cross Country Healthcare, Inc. misses on earnings expectations. Reported EPS is $-2.56476 EPS, expectations ...